Literature DB >> 21200182

Chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).

Donna M McDonald-McGinn1, Kathleen E Sullivan.   

Abstract

Chromosome 22q11.2 deletion syndrome is a common syndrome also known as DiGeorge syndrome and velocardiofacial syndrome. It occurs in approximately 1:4000 births, and the incidence is increasing due to affected parents bearing their own affected children. The manifestations of this syndrome cross all medical specialties, and care of the children and adults can be complex. Many patients have a mild to moderate immune deficiency, and the majority of patients have a cardiac anomaly. Additional features include renal anomalies, eye anomalies, hypoparathyroidism, skeletal defects, and developmental delay. Each child's needs must be tailored to his or her specific medical problems, and as the child transitions to adulthood, additional issues will arise. A holistic approach, addressing medical and behavioral needs, can be very helpful.

Entities:  

Mesh:

Year:  2011        PMID: 21200182     DOI: 10.1097/MD.0b013e3182060469

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  122 in total

1.  Unmasking of a Recessive SCARF2 Mutation by a 22q11.12 de novo Deletion in a Patient with Van den Ende-Gupta Syndrome.

Authors:  M F Bedeschi; L Colombo; F Mari; K Hofmann; A Rauch; B Gentilin; A Renieri; D Clerici
Journal:  Mol Syndromol       Date:  2011-05-18

2.  Mitochondrial Citrate Transporter-dependent Metabolic Signature in the 22q11.2 Deletion Syndrome.

Authors:  Eleonora Napoli; Flora Tassone; Sarah Wong; Kathleen Angkustsiri; Tony J Simon; Gyu Song; Cecilia Giulivi
Journal:  J Biol Chem       Date:  2015-07-28       Impact factor: 5.157

3.  Working Memory Impairments in Chromosome 22q11.2 Deletion Syndrome: The Roles of Anxiety and Stress Physiology.

Authors:  Ashley F P Sanders; Diana A Hobbs; David D Stephenson; Robert D Laird; Elliott A Beaton
Journal:  J Autism Dev Disord       Date:  2017-04

Review 4.  Understanding the role of Tbx1 as a candidate gene for 22q11.2 deletion syndrome.

Authors:  Shan Gao; Xiao Li; Brad A Amendt
Journal:  Curr Allergy Asthma Rep       Date:  2013-12       Impact factor: 4.806

5.  Neonatal screening for severe combined immunodeficiency.

Authors:  Jennifer M Puck
Journal:  Curr Opin Pediatr       Date:  2011-12       Impact factor: 2.856

6.  22q11.2 Microduplications: Two Clinical Reports Compared with Similar Cases from the Literature.

Authors:  Aderonke Oyetunji; Merlin G Butler
Journal:  J Pediatr Genet       Date:  2020-01-10

7.  Prenatal genetic testing with chromosomal microarray analysis identifies major risk variants for schizophrenia and other later-onset disorders.

Authors:  Gregory Costain; Donna M McDonald-McGinn; Anne S Bassett
Journal:  Am J Psychiatry       Date:  2013-12       Impact factor: 18.112

Review 8.  Mitochondria in complex psychiatric disorders: Lessons from mouse models of 22q11.2 deletion syndrome: Hemizygous deletion of several mitochondrial genes in the 22q11.2 genomic region can lead to symptoms associated with neuropsychiatric disease.

Authors:  Prakash Devaraju; Stanislav S Zakharenko
Journal:  Bioessays       Date:  2017-01-03       Impact factor: 4.345

9.  Lymphocyte Apoptosis and FAS Expression in Patients with 22q11.2 Deletion Syndrome.

Authors:  Dina M Aresvik; Torstein Øverland; Kari Lima; Rolf D Pettersen; Tore G Abrahamsen
Journal:  J Clin Immunol       Date:  2018-12-19       Impact factor: 8.317

Review 10.  Noninvasive prenatal testing: the future is now.

Authors:  Errol R Norwitz; Brynn Levy
Journal:  Rev Obstet Gynecol       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.